Integer Holdings ITGR Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Total sales by Product | ||||||
| Cardiac Rhythm Management & Neuromodulation | $168.26M— | —— | $169.16M-1.7% | $172M+7.3% | $160.35M— | |
| Cardio & Vascular | $261.73M— | —— | $277.15M-3.4% | $286.86M+10.8% | $258.87M— | |
| Other Markets | $9.58M— | —— | $21.39M+21.2% | $17.64M-2.9% | $18.18M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Integer Holdings break its business down?
- Integer Holdings (ITGR) reports total sales by product across 3 parts — Cardiac Rhythm Management & Neuromodulation, Cardio & Vascular and Other Markets. Each is extracted from the segment footnotes and tracked over time.
- Where does Integer Holdings's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Integer Holdings's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
